Literature DB >> 30905349

Lipid-metabolizing serine hydrolases in the mammalian central nervous system: endocannabinoids and beyond.

Myungsun Shin1, Timothy B Ware1, Hyeon-Cheol Lee2, Ku-Lung Hsu3.   

Abstract

The metabolic serine hydrolases hydrolyze ester, amide, or thioester bonds found in broad small molecule substrates using a conserved activated serine nucleophile. The mammalian central nervous system (CNS) express a diverse repertoire of serine hydrolases that act as (phospho)lipases or lipid amidases to regulate lipid metabolism and signaling vital for normal neurocognitive function and CNS integrity. Advances in genomic DNA sequencing have provided evidence for the role of these lipid-metabolizing serine hydrolases in neurologic, psychiatric, and neurodegenerative disorders. This review briefly summarizes recent progress in understanding the biochemical and (patho)physiological roles of these lipid-metabolizing serine hydrolases in the mammalian CNS with a focus on serine hydrolases involved in the endocannabinoid system. The development and application of specific inhibitors for an individual serine hydrolase, if available, are also described. This article is part of a Special Issue entitled Novel functions of phospholipase A2 Guest Editors: Makoto Murakami and Gerard Lambeau.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2‑Arachidonoylglycerol; Activity-based protein profiling (ABPP); Anandamide; Endocannabinoid; Phospholipase; Serine hydrolase

Mesh:

Substances:

Year:  2018        PMID: 30905349      PMCID: PMC6433413          DOI: 10.1016/j.bbalip.2018.08.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  171 in total

1.  Diacylglycerol lipase β inhibition reverses nociceptive behaviour in mouse models of inflammatory and neuropathic pain.

Authors:  J L Wilkerson; S Ghosh; D Bagdas; B L Mason; M S Crowe; K L Hsu; L E Wise; S G Kinsey; M I Damaj; B F Cravatt; A H Lichtman
Journal:  Br J Pharmacol       Date:  2016-04-08       Impact factor: 8.739

2.  Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway.

Authors:  Gabriel M Simon; Benjamin F Cravatt
Journal:  J Biol Chem       Date:  2006-07-03       Impact factor: 5.157

3.  The hereditary spastic paraplegia-related enzyme DDHD2 is a principal brain triglyceride lipase.

Authors:  Jordon M Inloes; Ku-Lung Hsu; Melissa M Dix; Andreu Viader; Kim Masuda; Thais Takei; Malcolm R Wood; Benjamin F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

4.  Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474.

Authors:  Annelot C M van Esbroeck; Antonius P A Janssen; Armand B Cognetta; Daisuke Ogasawara; Guy Shpak; Mark van der Kroeg; Vasudev Kantae; Marc P Baggelaar; Femke M S de Vrij; Hui Deng; Marco Allarà; Filomena Fezza; Zhanmin Lin; Tom van der Wel; Marjolein Soethoudt; Elliot D Mock; Hans den Dulk; Ilse L Baak; Bogdan I Florea; Giel Hendriks; Luciano De Petrocellis; Herman S Overkleeft; Thomas Hankemeier; Chris I De Zeeuw; Vincenzo Di Marzo; Mauro Maccarrone; Benjamin F Cravatt; Steven A Kushner; Mario van der Stelt
Journal:  Science       Date:  2017-06-09       Impact factor: 47.728

5.  A second fatty acid amide hydrolase with variable distribution among placental mammals.

Authors:  Binqing Q Wei; Tarjei S Mikkelsen; Michele K McKinney; Eric S Lander; Benjamin F Cravatt
Journal:  J Biol Chem       Date:  2006-10-02       Impact factor: 5.157

6.  Regulated endosomal trafficking of Diacylglycerol lipase alpha (DAGLα) generates distinct cellular pools; implications for endocannabinoid signaling.

Authors:  Ya Zhou; Fiona V Howell; Oleg O Glebov; David Albrecht; Gareth Williams; Patrick Doherty
Journal:  Mol Cell Neurosci       Date:  2016-09-03       Impact factor: 4.314

Review 7.  Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.

Authors:  Bradley J Turner; Kevin Talbot
Journal:  Prog Neurobiol       Date:  2008-01-16       Impact factor: 11.685

Review 8.  Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation.

Authors:  Joel E Schlosburg; Steven G Kinsey; Aron H Lichtman
Journal:  AAPS J       Date:  2009-01-29       Impact factor: 4.009

9.  Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3.

Authors:  Tobias Eisenberger; Rima Slim; Ahmad Mansour; Markus Nauck; Gudrun Nürnberg; Peter Nürnberg; Christian Decker; Claudia Dafinger; Inga Ebermann; Carsten Bergmann; Hanno Jörn Bolz
Journal:  Orphanet J Rare Dis       Date:  2012-09-02       Impact factor: 4.123

10.  N-acylethanolamine signalling mediates the effect of diet on lifespan in Caenorhabditis elegans.

Authors:  Mark Lucanic; Jason M Held; Maithili C Vantipalli; Ida M Klang; Jill B Graham; Bradford W Gibson; Gordon J Lithgow; Matthew S Gill
Journal:  Nature       Date:  2011-05-12       Impact factor: 49.962

View more
  3 in total

1.  The Endocannabinoid System May Modulate Sleep Disorders in Aging.

Authors:  Eric Murillo-Rodríguez; Henning Budde; André Barciela Veras; Nuno Barbosa Rocha; Diogo Telles-Correia; Diogo Monteiro; Luis Cid; Tetsuya Yamamoto; Sérgio Machado; Pablo Torterolo
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

2.  Inhibition of fatty acid amide hydrolase prevents pathology in neurovisceral acid sphingomyelinase deficiency by rescuing defective endocannabinoid signaling.

Authors:  Adrián Bartoll; Ana Toledano-Zaragoza; Josefina Casas; Manuel Guzmán; Edward H Schuchman; María Dolores Ledesma
Journal:  EMBO Mol Med       Date:  2020-10-05       Impact factor: 12.137

3.  The Phenotypic Spectrum of Patients with PHARC Syndrome Due to Variants in ABHD12: An Ophthalmic Perspective.

Authors:  Xuan-Thanh-An Nguyen; Hind Almushattat; Ine Strubbe; Michalis Georgiou; Catherina H Z Li; Mary J van Schooneveld; Inge Joniau; Elfride De Baere; Ralph J Florijn; Arthur A Bergen; Carel B Hoyng; Michel Michaelides; Bart P Leroy; Camiel J F Boon
Journal:  Genes (Basel)       Date:  2021-09-11       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.